Size | Price | Stock | Qty |
---|---|---|---|
1g |
|
||
2g |
|
||
5g |
|
||
10g |
|
||
25g |
|
||
Other Sizes |
|
Purity: ≥98%
Melatonin (Circadin; 5-Methoxy-N-acetyltryptamine; NSC-56423; NSC 113928; Regulin), an endogenous indoleamine neurohormone associated with control of the sleep–wake cycle, is a MT receptor agonist used as a dietary supplement for controlling of circadian rhythm. Melatonin is mostly secreted at night by the pineal gland.
Targets |
Microbial Metabolite; Human Endogenous Metabolite
|
||
---|---|---|---|
ln Vitro |
|
||
ln Vivo | |||
Cell Assay |
Cell lines: HepG2 cells
Concentrations: 1.2 mM Incubation Time: 24 h Method: Cells were treated with various concentrations of drug for 24 h. |
||
Animal Protocol |
|
||
References |
Molecular Formula |
C13H16N2O2
|
|
---|---|---|
Molecular Weight |
232.28
|
|
Exact Mass |
232.12
|
|
Elemental Analysis |
C, 67.22; H, 6.94; N, 12.06; O, 13.78
|
|
CAS # |
73-31-4
|
|
Related CAS # |
Melatonin-d4; 66521-38-8; Melatonin-d3; 90735-69-6; Melatonin-d7; 615251-68-8
|
|
Appearance |
Solid powder
|
|
SMILES |
CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC
|
|
InChi Key |
DRLFMBDRBRZALE-UHFFFAOYSA-N
|
|
InChi Code |
InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16)
|
|
Chemical Name |
N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide
|
|
Synonyms |
|
|
HS Tariff Code |
2934.99.9001
|
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
|
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
|
|||
---|---|---|---|---|
Solubility (In Vivo) |
5%absolute ethyl alcohol + 95%Corn oil: 2.3mg/ml (9.90mM) (Please use freshly prepared in vivo formulations for optimal results.)
|
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 4.3051 mL | 21.5257 mL | 43.0515 mL | |
5 mM | 0.8610 mL | 4.3051 mL | 8.6103 mL | |
10 mM | 0.4305 mL | 2.1526 mL | 4.3051 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
NCT Number | Recruitment | interventions | Conditions | Sponsor/Collaborators | Start Date | Phases |
NCT05257291 | Active Recruiting |
Drug: Melatonin | Essential Hypertension | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia |
February 2, 2018 | Phase 2 |
NCT05654415 | Active Recruiting |
Other: Melatonin Other: Deprivation |
Epilepsy | IRCCS National Neurological Institute "C. Mondino" Foundation |
September 1, 2021 | Not Applicable |
NCT01863446 | Active Recruiting |
Device: Lighting1 Device: Lighting2 |
Pregnancy | Brigham and Women's Hospital | May 2013 | Not Applicable |
NCT00512070 | Active Recruiting |
Drug: olanzapine and melatonin | Schizophrenia Bipolar Disorder Obesity |
Seattle Institute for Biomedical and Clinical Research |
July 2007 | Not Applicable |
NCT05042700 | Active Recruiting |
Drug: Melatonin Drug: Placebo |
Low Anterior Resection Syndrome | Ismail Gögenur | October 13, 2021 | Phase 2 |
Therapeutic effect of melatonin in mouse pups on necrotizing enterocolitis (NEC). Theranostics . 2020 Jun 19;10(17):7730-7746. td> |
Melatonin effects are associated with the lamina propria Th17/Treg balance. Theranostics . 2020 Jun 19;10(17):7730-7746. td> |
Melatonin effects require Th17/Treg balance. Theranostics . 2020 Jun 19;10(17):7730-7746. td> |
Melatonin inhibits cell proliferation. Front Pharmacol . 2022 Sep 26:13:1007006. td> |
Analysis of gene expression changes induced by melatonin. Front Pharmacol . 2022 Sep 26:13:1007006. td> |
Inhibition of gonadotropin-releasing hormone (GnRH)-induced luteinizing hormone (LH) release from neonatal rat gonadotrophs by melatonin. Dispersed cells were attached to culture plates (∼150 000 cells/well) and cultured in 95% air-5% CO2. Physiol Rev . 1998 Jul;78(3):687-721. td> |